Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
NGS Oncology Melanoma Profile (Tissue Only) Diagnostic Laboratory Services, Inc. United States | 1 | 41 |
|
OnkoRisk Hereditary Oncology Plus Panel BioReference Health United States | 97 | 77 |
|
OnkoRisk Hereditary Oncology Management Panel BioReference Health United States | 47 | 17 |
|
OnkoRisk Women's Hereditary Cancer Panel BioReference Health United States | 34 | 18 |
|
OnkoRisk Hereditary Urology Panel BioReference Health United States | 27 | 19 |
|
Diagnostic Laboratory Services, Inc. United States | 5 | 40 |
|
Hereditary Melanoma and/or Pancreatic Cancer, CDKN2A Gene GeneKor MSA Greece | 3 | 1 |
|
Molecular Genetics Laboratory North York General Hospital Canada | 3 | 7 |
|
Cell-Free DNA BRAF V600 Test, Blood Mayo Clinic Laboratories Mayo Clinic United States | 1 | 1 |
|
PathGroup United States | 73 | 505 |
|
Clinical Cancer Genomics Laboratory University of California, San Francisco United States | 2 | 2 |
|
GoPath Diagnostics United States | 1 | 3 |
|
KRAS, BRAF, and NRA Mutation Analysis PathGroup United States | 23 | 3 |
|
BRAF and MSI Mutation Analysis PathGroup United States | 15 | 1 |
|
KRAS, BRAF, NRAS and MSI Mutation Analysis PathGroup United States | 23 | 3 |
|
BRAF, NRAS, KIT Mutation Analysis PathGroup United States | 16 | 3 |
|
BRAF, EGFR, KRAS Mutation Analysis PathGroup United States | 25 | 3 |
|
PathGroup United States | 15 | 2 |
|
Laboratory for Molecular Pediatric Pathology Boston Children's Hospital United States | 4 | 1 |
|
PrimBio Research Institute United States | 60 | 50 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.